Housing these resources on LabXchange.org extends the Amgen Foundation’s ability to support any learner interested in scientific research from anywhere around the world.

Amgen,bringing better, healthier lives to people worldwide throughbiotechnology. Additional funding is provided by the John M. Olin Foundation, theRandolph Foundation and the Lynde and Harry ...

While Regeneron may have lost its latest bid to block the launch of Amgen’s Eylea biosimilar Pavblu, the New York-based pharma isn’t throwing in the towel just yet. At the same time ...

Amgen is posting strong growth across its diversified-medicines portfolio. A new weight-loss drug candidate could be a game-changer for the company. Trading at 17 times earnings, the stock offers ...

Amgen, a global biotechnology leader highlighting profound research and development capabilities and biomanufacturing, showcases its latest achievements in the field of innovative medicines under the ...

Oct. 15, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN ... parallel-group trial will be presented at the Myasthenia Gravis Foundation of America (MGFA) Scientific Session during the American Association ...